TF6-73099-93576
2 vaccinations
1 coded response
4 check-ins
0 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 973 / OR
- Registered
- 2022-10-15
- Relationship
- Child or adolescent in my care
- Guardian
- D22-39889-19814
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-10-06
Dose 1 — ModernaCo-administered: Flu:Hepatitis B:Pneumonia:Polio:Tetanus
-
2022-10-15
Registered in v-safe
- 2022-10-15
-
2022-11-10
Dose 2 — Moderna
- 2022-11-17
- 2022-12-22
-
2023-02-09
Survey response — 3 months, dose 2, under 3MedDRA: Benign enlargement of the subarachnoid spaces, Nasopharyngitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-09
Report sent to call center — 3 months, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-06 | Moderna | Flu:Hepatitis B:Pneumonia:Polio:Tetanus |
| 2 | 2022-11-10 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Benign enlargement of the subarachnoid spaces | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release